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The need to establish sustainable public and patient involvement in 
research in low and middle income countries 
 
 
Global health research continues to face enormous inequities. While low and middle income 
countries (LMICs) face an inordinate burden of preventable mortality and morbidity very little 
research funding is directed to address these problems. This has historically been called the 
10/90 divide, that is, only 10% of research funding is devoted to addressing over 90% of the 
global disease burden 1. The recognition of the nature and extent of this disparity has shaped 
the discussion about the ethics of research in LMICs. A central question of this discussion 
relates to what researchers and funders from high income countries owe participants and others 
impacted by research in LMICs 2. This comes from a growing awareness that research 
conducted in LMICs, even under the best of circumstances is potentially exploitative 3, with its 
benefits often unfairly distributed. While there has been an expansion in international 
guidelines and growing awareness of these issues, these inequities remain. In attempting to 
address these issues Costello and Zumla 4 call for researchers to move away from more 
traditional ‘semicolonial’ approaches to research, to models that emphasise more equal 
partnerships and collaboration  that empowers patients and the public in the research process, 
emphasising ownership, sustainability and the development of research capacity. 
 
The establishment of sustainable institutions and policy to promote greater patient and public 
involvement (PPI) in research has the potential to address some of these concerns and is now 
considered non-negotiable in the context of research in higher income countries. PPI in 
research can be defined as research that is carried out ‘with’ or ‘by’ patients or members of the 
public rather than ‘to’, ‘about’ or ‘for’ them 5. In other words, this means that patients and the 
public are active partners in research, rather than simply being used as participants in research. 
Patient and public involvement in research can thus involve a range of activities and different 
types of engagement throughout the research process. Practically, patients or the public could 
be involved in identifying key research questions, assisting with study design, defining 
outcomes, collecting and analysing data and disseminating and implementing results. The 
similar concept of community engagement involves engaging “potential participants and 
communities in a meaningful participatory process that involves them in an early and sustained 
manner in the design, development, implementation, design of the informed consent process 
and monitoring of research, and in the dissemination of its results” 6. 
 
PPI in research has become increasingly common in a number of high income countries, 
including the UK, Europe, Canada, Australia and the USA. A growing number of organisations 
exist to support the expansion of PPI in research; for example the Patient Centred Outcomes 
Research Institute (PCORI)1 in the USA and INOLVE2 in the UK. While PPI in research in 
LMICs has been called for in international guidelines (e.g., The Council for International 
Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for Health-
related Research Involving Humans)6 and its importance long recognised 7, there remain few 
institutions and limited policy to support sustainable PPI in LMICs themselves.  
 
There are a number of good reasons to support the establishment of institutions and policy to 
promote sustainable PPI in research and why high income countries have a responsibility to 
assist. The first are ethical. Already alluded to above, PPI in research is increasingly viewed as 
a meaningful response to the potentially exploitative nature of research and in addressing the 
unfair distribution of its benefits 7. PPI has the potential to enhance the protection of individuals 
and others impacted by research; it can ensure the social value of research and enhance the 
potential benefits for participants; it also creates legitimacy and promotes shared responsibility 
with researchers 8, 9. Put another way, PPI allows those directly affected by the research to have 
a say in how research is conducted, how any risks should be mediated and how any potential 
benefits should be distributed. In addition to this there is growing empirical evidence which 
documents the benefits of PPI for individuals and communities. These include greater health 
literacy and contributions to improvements in the delivery of healthcare 10. 
 
Second, there is already a substantial pool of expertise and evidence that can be drawn upon to 
assist in the development of policy and the establishment of institutions to support PPI. This 
includes a range of guidance, best practice standards 11 and empirical research 10, 12 that could 
 
1 https://www.pcori.org/ 
2 https://www.invo.org.uk 
be used to inform the creation of PPI policy in LMICs. This is not to say that research in this 
area is not without its shortcomings or that the extent of these benefits are settled 13, further 
research is needed into the range of contextual factors that impact on PPI in research and its 
success or otherwise. In addition to this, there is also a vast literature that discusses and critiques 
PPI in healthcare in LMICs. As well as offering practical insights like the above literature, it 
provides a valuable account of the lessons learnt in relation to engaging with individuals and 
communities in LMICs, that can be used to develop more equal research partnerships 14. 
 
Finally, research itself benefits from PPI. In the context of the UK, there has been growing 
criticism of the way in which PPI in research excludes Black, Asian and minority ethnic 
(BAME) communities and their perspectives 15, 16. PPI has been shown to increase the 
participation of BAME and other marginalised groups, creating research that is more relevant 
to all individuals and communities 17. The knowledge and experiences of researchers will often 
be very different to those utilising health services or living with a medical condition and thus 
patients and the public will  have insights and experiences that would otherwise be overlooked. 
For research conducted in LMICs researchers may also be faced with a range of cultural and 
linguistic differences. In a systematic review exploring the impact of patient and public 
involvement in research Brett, Staniszewska 10 found that among other benefits of PPI, 
researchers gained “new insights into their work and … a greater understanding of the area 
under study”. Furthermore PPI can facilitate improvements in recruitment, “the quality and 
relevance of data collected… and wider dissemination of the results”. In addition to this, the 
lessons learnt from implementing PPI in LMICs could also serve to inform more inclusive and 
relevant research in higher income countries. 
 
In saying all of this, while institutionalising PPI in LMICs could address a number of 
shortcomings in global health research, caution is still warranted. While a number of models 
could be applied to shape PPI in LMICs, it cannot be taken for granted that these will ‘work’ 
when employed in different circumstances. Care is also needed to ensure that policies and 
institutions don’t re-enforce existing hierarchy or undermine the participation of the most 
vulnerable 18 19.  
 
With these caveats in mind, establishing PPI policies and institutions in LMICs has promise to 
move toward justice and greater inclusivity in research, going some of the way to addressing 
the well documented inequities and exploitation that remain pervasive issues. This more 
inclusive model could also benefit the development of more diverse models of PPI in higher 
income countries 15, help enable a greater understanding about the factors influencing BAME 
involvement in health and social care research 20 and in producing research that is more relevant 
not only to otherwise marginalised individuals and communities 17 but to broader populations 
and society more generally. PPI is a meaningful and practical response that has the potential to 
empower patients and the public, contributing to greater ownership, sustainability and the 
development of research capacity. Funders and those working in LMICs should give serious 
consideration to not just how they can involve potential participants in research but how they 
can promote more sustainable, methods of PPI based upon empowerment, diversity and 
inclusivity. 
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